Advertisement

Topics

Latest "Extab Corporation" News Stories

15:05 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Extab Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Extab Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Extab Corporation for you to read. Along with our medical data and news we also list Extab Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Extab Corporation Companies for you to search.

Showing "Extab Corporation" News Articles 1–25 of 475

Relevant

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated person...


Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and t...


Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated pe...

Orion Corporation: Managers' transactions - Heikki Westerlund

ORION CORPORATION      MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Heikki Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their...

Orion Corporation: Managers' transactions - Agendum Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 30 APRIL 2018 at 17.15 EEST Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their c...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. ...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated...

Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä

ORION CORPORATION         MANAGERS' TRANSACTIONS 8 MAY 2018 at 16.30 EETS Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associ...

International Stem Cell Corporation Granted Key Patent in US

CARLSBAD, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a key patent (US9926529B2) on ...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab (“OGGL”). Mr. Vinson has over 35-years experience in managing the marketing efforts for innovative technology in emerging markets. He began sales efforts in the technology s...

Geron Corporation Reports First Quarter 2018 Financial Results

MENLO PARK, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2018. First Quarter 2018 Results For the first quarter of 2018, the company reported operating revenues of $318,000 and operating expenses of $7.8 million compared to $537,000 and $8.0 million, respectively, for the comparable 2017 period...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that ISCO’s Research and Development team has developed novel methods that efficiently generate...

Vericel Corporation Prices $65 Million Public Offering of Common Stock

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock, at a price to the public of $13.00 per share.  The gross proceeds to Vericel from this offerin...

International Stem Cell Corporation to Launch Advanced Joint Supplement

CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans to launch its advanced joint supplement, designed to potentially reduce jo...

ContraFect Corporation Announces Proposed Public Offering of Common Stock

YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that it has commenced an underwritten public offering of its common stock. All shares in the offering are to be sold by ContraFect. Th...

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the pricing of its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $2.00 per share....

Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam

Regalia®, Grandevo® and Majestene® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, to...

Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices

EAST RUTHERFORD, N.J., April 19, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced a commitment to provide its stockholders with additional information regarding its environmental, social and governance (ESG) practices.  Cambrex’s commitment to the environment, ...

Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services

Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program.  Arrayit’s new CLIA license, issued in conjunction with the Department of Health an...

Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists

Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP).  Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human ...

Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement

Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for reimbursement under Medicare and Medicaid.  Accuracy testing, supervised by the College of American Pathologists (CAP), assesses quantitative measurements of the immunoglobulin E (...

Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network

Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company has engaged a nationwide network of professional sales representatives (“sales reps”) to sell and distribute t...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks